High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Suraya Elfrink, Charlotte M. de Winde, Michiel van den Brand, Madeleine R. Berendsen, Margaretha G.M. Roemer, Frank Arnold, Luuk Janssen, Alie van der Schaaf, Erik W.L. Jansen, Patricia J.T.A. Groenen,

Blood · 2019 · 22 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

Key Points Loss-of-function mutations in CD37 occur predominantly in diffuse large B-cell lymphoma at immune-privileged sites. CD37-mutated lymphoma B cells show impaired CD37 cell-surface localization, which may have implications for anti-CD37 therapies.

References

22